TM Bioscience Corporation – Trademark Portfolio

Entity Type: 03

TM Bioscience Corporation holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. The owner is based in Toronto, Ontario.

439 University Avenue, Suite 1100

Toronto, Ontario M5G 1Y8 , CA

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TM Bioscience Corporation's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (5 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does TM Bioscience Corporation have?

TM Bioscience Corporation has 9 U.S. trademarks filed with the USPTO.

What trademark classes does TM Bioscience Corporation file in?

TM Bioscience Corporation files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is TM Bioscience Corporation's trademark registration success rate?

TM Bioscience Corporation has a 0% trademark registration rate, with 0 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.